Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 522)
Posted On: 10/01/2022 9:46:50 AM
Post# of 154853
Avatar
Posted By: Drano
Just look at how great Remdesivir has been for the world. This is from a Washington Post email, so there is no link to post.

Quote:
According to findings from researchers at the NYU Grossman School of Medicine and NYU Long Island School of Medicine, two kidney transplant patients were treated with remdesivir after developing covid-19. They were readmitted to the hospital after developing symptoms including fatigue, cough and a fever, despite being vaccinated.

When doctors tested the patients, they identified a gene mutation that wasn't previously present and appeared only after the patients took the antiviral treatment. The mutation made the virus more resistant to remdesivir.

Remdesivir — developed initially to treat hepatitis C — is one of the few antiviral therapies approved by the Food and Drug Administration to treat hospitalized coronavirus patients.

“In the future, physicians might also screen for such mutations before making treatment decisions for their most vulnerable patients,” Adriana Heguy, one of the study authors, said in a statement.














(5)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site